Figure 6.
CT changes on week 14 of treatment. Response to combination of everolimus and sorafenib in CT at week 14 of study treatment showing changes according to RECIST 1.1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.